Barnaba V, Franco A, Paroli M, Benvenuto R, De Petrillo G, Burgio V L, Santilio I, Balsano C, Bonavita M S, Cappelli G
Molecular and Cellular Immunology Unit, Fondazione A. Cesalpino, University of Rome La Sapienza, Italy.
J Immunol. 1994 Mar 15;152(6):3074-87.
Highly purified CD4+ T cells isolated from liver biopsies of patients with hepatitis B virus-induced CAH had a strong cytotoxic activity and were comprised of a substantial number of cells (25%-40%) expressing CD56 surface marker. These cells were absent in CD4+ T cells from the peripheral blood of CAH patients or normal controls and these suspensions did not have cytotoxic activity. CD4+CD56+ T cells were further characterized by studies at the clonal level. A total of 71 hepatitis B envelope antigen-specific CD4+ T cell clones was investigated (23 from liver biopsies, 48 from peripheral blood of patients or normal vaccinated individuals). A total of 16 out of 23 (69.5%) of the clones from liver biopsies, but only 4.1% (2 out of 48) of those from PBLs, expressed CD56. A clone was defined as CD56+ when 40% or more of the cells expressed the marker. Production of TNF-alpha, IL-4, IL-5, IL-2, and IFN-gamma was investigated in 15 CD4+CD56+ and in 18 CD4+CD56- T cell clones, which shared the same HLA restriction element (DR2w15) and the same fine specificity (peptide 193-207 of the S region). All of the clones from the two groups released TNF-alpha and IL-2. However, all of the CD4+CD56+ T cell clones produced IFN-gamma but not IL-4 and IL-5 (Th1-like cell clones). Fourteen of the CD4+CD56- clones released IFN-gamma, IL-4, and IL-5 (Th0-like cell clones); three produced IL-4 and IL-5 but not IFN-gamma (Th2-like cell clones); and only one had a Th1 cytokine secretion profile. Cell fractionating studies within single CD4+CD56+ T cell clones showed that cells expressing high density CD56 had a stronger cytotoxic activity and produced higher levels of IFN-gamma than cells with low density CD56, thus further supporting a correlation between CD56 expression and cell functions. The results indicate that: 1) in CAH patients, cytotoxic CD4+ T cells with a Th1 cytokine secretion profile are compartmentalized in the liver, 2) these cells may be identified by the expression of CD56, 3) the expansion of these cells may be facilitated by antigenic stimulation within the inflammatory environment of the liver, and 4) CD4+CD56+ cells may play a pathogenetic role in hepatitis B virus infection.
从乙型肝炎病毒所致慢性活动性肝炎(CAH)患者肝活检中分离出的高度纯化的CD4⁺ T细胞具有很强的细胞毒性活性,且由大量表达CD56表面标志物的细胞(25% - 40%)组成。这些细胞在CAH患者外周血或正常对照的CD4⁺ T细胞中不存在,且这些细胞悬液没有细胞毒性活性。通过克隆水平的研究对CD4⁺CD56⁺ T细胞进行了进一步表征。共研究了71个乙型肝炎包膜抗原特异性CD4⁺ T细胞克隆(23个来自肝活检,48个来自患者外周血或正常接种疫苗个体)。来自肝活检的23个克隆中有16个(69.5%)表达CD56,但来自外周血淋巴细胞(PBLs)的克隆中只有4.1%(48个中的2个)表达CD56。当40%或更多细胞表达该标志物时,一个克隆被定义为CD56⁺。在15个CD4⁺CD56⁺和18个CD4⁺CD56⁻ T细胞克隆中研究了肿瘤坏死因子-α(TNF-α)、白细胞介素-4(IL-4)、白细胞介素-5(IL-5)、白细胞介素-2(IL-2)和干扰素-γ(IFN-γ)的产生,这些克隆具有相同的人类白细胞抗原(HLA)限制元件(DR2w15)和相同的精细特异性(S区肽段193 - 207)。两组的所有克隆都释放TNF-α和IL-2。然而,所有CD4⁺CD56⁺ T细胞克隆都产生IFN-γ,但不产生IL-4和IL-5(Th1样细胞克隆)。14个CD4⁺CD56⁻克隆释放IFN-γ、IL-4和IL-5(Th0样细胞克隆);3个产生IL-4和IL-5但不产生IFN-γ(Th2样细胞克隆);只有1个具有Th1细胞因子分泌谱。对单个CD4⁺CD56⁺ T细胞克隆内的细胞分级研究表明,表达高密度CD56 的细胞比低密度CD56 的细胞具有更强的细胞毒性活性且产生更高水平的IFN-γ,从而进一步支持CD56表达与细胞功能之间的相关性。结果表明:1)在CAH患者中,具有Th1细胞因子分泌谱的细胞毒性CD4⁺ T细胞在肝脏中分隔存在;2)这些细胞可通过CD56的表达来鉴定;3)这些细胞的扩增可能在肝脏炎症环境中的抗原刺激作用下得以促进;4)CD4⁺CD56⁺细胞可能在乙型肝炎病毒感染中发挥致病作用。